Cargando…
Inhibition of centrosomal protein 164 sensitizes rhabdomyosarcoma cells to radiotherapy
Rhabdomyosarcoma is the second most common malignant tumor of the heart in infants and children and cannot often be resected completely. Chemotherapy and radiotherapy have a critical role in relieving symptoms and prolonging survival; therefore, enhancing the sensitivity of rhabdomyosarcoma to radio...
Autores principales: | Liu, Jianzhou, Wang, Zhiju, Li, Xiaofeng, Zhang, Xu, Zhang, Chaoji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443223/ https://www.ncbi.nlm.nih.gov/pubmed/28565843 http://dx.doi.org/10.3892/etm.2017.4281 |
Ejemplares similares
-
Centrosomal Protein 70 Is a Mediator of Paclitaxel Sensitivity
por: Shi, Xingjuan, et al.
Publicado: (2017) -
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression
por: Perrone, Clara, et al.
Publicado: (2022) -
Centrosomes are PKA's sensitive spot
por: Short, Ben
Publicado: (2012) -
The impact of radiotherapy on clinical outcomes in parameningeal rhabdomyosarcoma
por: Choi, Yunseon, et al.
Publicado: (2016) -
CentrosomeDB: a human centrosomal proteins database
por: Nogales-Cadenas, Rubén, et al.
Publicado: (2009)